The side effects of immune checkpoint inhibitor therapy on the endocrine system

Immune checkpoint inhibitors (ICIs) are a relatively newer class of drugs approved for the treatment of malignancies such as melanoma, renal, bladder and lung cancer. Immune-related adverse events (IrAEs) involving the endocrine system are a common side effect of these drugs. The spectrum of endocri...

Descripción completa

Detalles Bibliográficos
Autores principales: Goyal, Itivrita, Pandey, Manu Raj, Sharma, Rajeev, Chaudhuri, Ajay, Dandona, Paresh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205006/
https://www.ncbi.nlm.nih.gov/pubmed/35435341
http://dx.doi.org/10.4103/ijmr.IJMR_313_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205006/
https://www.ncbi.nlm.nih.gov/pubmed/35435341
http://dx.doi.org/10.4103/ijmr.IJMR_313_19

Ejemplares similares